Millbray – Eakon Therapeutics has signed a lease that will enable the biotech company to expand as well as move its headquarters to a modern technology and life sciences campus in Millbray.
The biotech company signed a lease for 285,000 square feet of office and laboratory space at the Alexandria Life Sciences Campus in Millbrae, Eikon said Thursday. The complex is located near the corner of Rollins Road and Adrian Road.
“We are proud to expand our presence in this area,” said Roger Perlmutter, CEO of Eakon Therapeutics.
The company said that Eikon is moving its headquarters from Hayward to Millbray.
Potentially 750 Eikon employees could work in the new Millbrae offices, the company estimates.
Alexandria Real Estate, a Pasadena-based developer with several major office projects in the Bay Area, is developing a larger complex in Millbrae that will total 637,000 square feet.
Alfred “Freddie” Bowie, Chief Financial Officer of Eakon Therapeutics, said, “Eacon is at an exciting stage of development that has benefited greatly from a diverse pool of talent across research, engineering and technology.”
The new technical complex is expected to be three office buildings with parking garages and a convenience center as the primary structures.
The buildings are designed to include modern office spaces as well as advanced research and laboratory facilities. The complex is scheduled to be completed sometime in 2024.
The technical complex under construction is across the street from the Millbrae Transit Center. Both BART and Caltrain serve the transit hub. This enables people to have rapid transit links to large cities such as San Jose, Oakland and San Francisco.
“With strong public transportation access, as well as uniquely inspiring design and amenities, this new complex will enable Econ to recruit the best talent,” said Terezia Nemeth, executive vice president of Alexandria Real Estate and regional market manager for the Bay Area.
Cushman & Wakefield, a commercial real estate firm, represents Ekon Therapeutics in its search for office space.
The biotech company has developed technologies to track the real-time activities of proteins within cells as a way to develop new treatments for a range of dangerous diseases.
“Eacon Therapeutics captures the best of the Bay Area’s culture of mission-driven innovation,” said Tom Williams, City Manager of Millbray. “This is an exciting time for future development in our city.”